Analyst Price Targets — PGR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 19, 2026 1:06 pm | — | UBS | $238.00 | $217.67 | TheFly | Progressive price target raised to $238 from $234 at UBS |
| October 15, 2026 12:29 pm | — | BMO Capital | $216.00 | $218.46 | TheFly | Progressive price target lowered to $216 from $221 at BMO Capital |
| October 15, 2026 9:08 am | Elyse Greenspan | Wells Fargo | $196.00 | $213.46 | StreetInsider | Progressive Corp. (PGR) PT Lowered to $196 at Wells Fargo |
| October 7, 2026 9:09 am | — | HSBC | $216.00 | $212.05 | TheFly | Progressive price target raised to $216 from $214 at HSBC |
| September 21, 2026 9:16 am | Gregory Peters | Raymond James | $245.00 | $213.48 | StreetInsider | Raymond James Reiterates Outperform Rating on Progressive Corp. (PGR) |
| September 16, 2026 9:30 am | Yaron Kinar | Mizuho Securities | $230.00 | $221.31 | TheFly | Progressive price target lowered to $230 from $236 at Mizuho |
| August 27, 2026 11:08 am | Brian Meredith | UBS | $234.00 | $222.51 | TheFly | Progressive price target raised to $234 from $225 at UBS |
| August 20, 2026 11:47 am | Harry Fong | Roth Capital | $245.00 | $217.27 | TheFly | Progressive price target raised to $245 from $235 at Roth Capital |
| August 19, 2026 1:48 pm | Alex Scott | Goldman Sachs | $230.00 | $216.15 | StreetInsider | Goldman Sachs Reiterates Buy Rating on Progressive Corp. (PGR) |
| August 19, 2026 1:47 pm | Andrew Andersen | Jefferies | $228.00 | $216.03 | StreetInsider | Jefferies Reiterates Hold Rating on Progressive Corp. (PGR) |
Latest News for PGR
MAYFIELD VILLAGE, OHIO, Oct. 27, 2026 (GLOBE NEWSWIRE) -- As previously announced, The Progressive Corporation (NYSE: PGR) will host an Investor Relations conference call on Tuesday, November 3, 2026, beginning at 9:30 a.m. eastern time. This quarterly call, which will consist of both a conference call and audio-only webcast, is scheduled to last 60 minutes and will consist of a question-and-answer session with…
The Progressive Corporation (NYSE: PGR - Get Free Report) insider Steven Broz sold 1,225 shares of the firm's stock in a transaction on Thursday, October 22nd. The shares were sold at an average price of $223.32, for a total transaction of $273,567.00. Following the completion of the transaction, the insider directly owned 28,807 shares in the
NEW YORK--(BUSINESS WIRE)---- $TGTX--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced initial results from the Company's Phase 1 study evaluating azercabtagene zapreleucel (azer-cel), an investigational, allogeneic CD19-directed chimeric antigen receptor (CAR) T-cell therapy, in patients with progressive multiple sclerosis (MS). The data represent the first reported clinical evaluation of an allogeneic…
Single-dose miv-cel continues to demonstrate promising clinical benefit in progressive multiple sclerosis, achieving robust CAR T-cell penetration in the central nervous system (CNS) and improving disability scores while removing the need for chronic immunotherapies
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #CARTCellTherapy--Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.